High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma

The development of somatostatin analogs for the treatment of pituitary Cushing's disease has been based on somatostatin receptor expression analyses of small cohorts of pituitary adenomas. Additionally, the classification of pituitary adenomas has recently changed. To enable progress with this...

Descripción completa

Detalles Bibliográficos
Autores principales: Behling, Felix, Honegger, Jürgen, Skardelly, Marco, Gepfner-Tuma, Irina, Tabatabai, Ghazaleh, Tatagiba, Marcos, Schittenhelm, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304820/
https://www.ncbi.nlm.nih.gov/pubmed/30627156
http://dx.doi.org/10.1155/2018/1763735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304820/
https://www.ncbi.nlm.nih.gov/pubmed/30627156
http://dx.doi.org/10.1155/2018/1763735

Ejemplares similares